Drugs Controller General India (DCGI) took strict measures on Roche's Avastin (Bevacizumab Injection) after some reports on loss of visions. It is noted that opthalmic injection of Avastin leads to blindness in some patients which is not approved for intra-vitrieal use in India as per DCGI.



